Grant Impact

Mladen Vranic, OC MD DSc

Mladen Vranic is best known for his work in glucose tracer methodology to study the effects of exercise and stress in diabetes. He came to Canada to work with Charles H Best, co-discoverer of insulin, and was first funded by the Banting Research Foundation in 1966 for his work on glucagon physiology. Glucagon plays a…

Grant Impact

Charles H Hollenberg, OC MD FRSC

Charles Hollenberg was a physician, administrator, teacher and researcher. Born in Manitoba and educated at the University of Manitoba, he started his research career in 1960 at McGill University. After a decade there, he moved to the University of Toronto and became Chair of the Department of Medicine, where he transformed it into a place…

Grant Impact

Brenda L Gallie, CM MD FRCSC

Brenda Gallie is a world-renowned ophthalmologist known for her contributions to the prevention, diagnosis and treatment of retinoblastoma, a childhood eye cancer. In 1983, shortly after being appointed assistant professor of ophthalmology at the University of Toronto, Dr Gallie received a Banting Research Foundation grant to study the mutations of retinoblastoma, a rare form of…

2017

Julien van Grevenynghe, PhD

Department of Infectious diseases, immunity, cancer and epidemiology, INRS – Institut Armand-Frappier and the Université du Québec Autophagy regulates CD8 T-cell killing activity during chronic HIV-1 infection Autophagy, a natural self-destructive process in cells, eliminates some viruses from cells, and also plays a role in shaping functions of T cells, a primary part of the…

2017

Adena Scheer, MD

Department of Surgery, St Michael’s Hospital, Li Ka Shing Knowledge Institute, and the University of Toronto Cross-cultural communications in breast cancer treatment Among minorities, disparities in breast cancer treatments have been demonstrated across the developed world and have been associated with worse cancer outcomes. In Canada we have the highest rate of foreign-born individuals among…

2017

Gareth Lim, PhD

CRCHUM, Department of Medicine, Université de Montréal Evaluating the therapeutic potential of 14-3-3ζ for the treatment of obesity Approximately 25% of Canadians are either overweight or obese. Current therapies have only modest success in reducing body weight, and surprisingly, none directly target fat cells, which are key in the development of obesity.

2017

Catherine Larochelle, MD PhD

CRCHUM, Department of Neurosciences, Université de Montréal Molecular mechanisms underlying T lymphocytes interactions with oligodendrocytes in neuroinflammation In multiple sclerosis (MS), there is an abnormal response of immune cells against cells of the brain and spinal cord. Oligodendrocytes, the myelin-producing cells that support and insulate neurons, are injured by the inflammatory response, leaving neurons vulnerable.…

2017

Jennifer Gordon, PhD

Department of Psychology, University of Regina HPA axis dysregulation in the etiology of perimenopausal depression Women are 2-4 times more likely to develop depression during perimenopause, the menopause transition phase, than at any other time in their lives. Dr Gordon proposes that increased estrogen fluctuation during this phase may trigger dysregulation of the hypothalamic-pituitary-adrenal (HPA)…

2017

Florian Bentzinger, PhD

Department of Pharmacology-Physiology, Université de Sherbrooke Niche regulation of muscle stem cell specification Dr Bentzinger’s group studies the role of regulatory signals in the microenvironment where skeletal muscle stem cells (MuSCs) reside. Understanding how this so-called “stem cell niche” controls MuSCs and how these instructive mechanisms become disrupted in aging and disease, could help in…